NAME Unidad de Imagen Molecular – CIC biomaGUNE
La Unidad de Imagen Molecular ofrece recursos de imagen nuclear de última generación en tomografía por emisión de Positron (PET), tomografía computarizada de emisión de fotones único (SPECT), tomografía computarizada (TC), resonancia magnética (RM) con un animalario inegrado para realizar pruebas preclínicas en animales de diferentes formulaciones y dispositivos implantables, y desarrollo de agentes de contraste. El uso de moléculas radiomarcadas y agentes de contraste de RMN permite realizar pruebas metabólicas y ADME (adsorción, distribución, metabolismo y excreción) en roedores por PET y RMN.
FIELDS OF APPLICATION
Biomedical consumables
Electromedical devices
Medical Image
Orthopedic and rehabilitation Technology
MOST OUTSTANDING EQUIPMENT AND COMPONENTS
-
Animal Facility
The Animal Platform is accredited by AAALAC, has the capacity to house up to 800 rodents (mouse and rat) and performs comprehensive monitoring of animal welfare during procedures.
-
Bruker · Magnetic Resonance Imaging System · Biospec 117/16 USR
Equipped with a high performance 9 cm I.D. (750 mT/m switchable within 100 µs) interfaced to a Bruker AVANCE III console. The console is configured with full imaging capabilities: 4 RF transmitters, one broadband RF transmitter and 8 RF receivers. Dedicated RF-coils of different sizes for optimized rat brain, mouse brain, rat heart/body and mouse heart/body are available and includes state-of-the- art phase array assemblies. Additional RF volume/surface coils to perform 13C, 19F and 31P MRS are also available. A MR compatible holder and SAII Model 1030 Monitoring & Gating System (Small Animal Instruments Inc) is used to monitor the animal during the imaging session. 16 cm Zero boil off horizontal bore magnet.
-
Bruker · Minispec mq60
Magnetic resonance spectrometer of temporal domine for the acquisition of temporary constant T1 and T1. Magnetic field 1.4 Teslas. Working frequency 60 MHz.
-
IBA 18/9 · Cyclotron
Particle accelerator for the generation of Positron emitting isotopes.
The cyclotron is capable to accelerate protons and deuterons to nominal energies of 18 and 9 MeV, respectively.
It is equipped with seven targets for the routine production of [18F]F-, [18F]F2, [13N]NH4+, [15O]O2, [11C]CO2 and [11C]CH4.
A solid target, suitable to produce other positron emitters such as 89Zr or 64Cu is also available. -
Molecubes · Trimodal PET/SPET/CT System
The system comprises of three scanners to deliver multi-modal data, which are co registered automatically.
1) a high-performance preclinical PET imager (β-CUBE)
2) a high-sensitive, high-resolution SPECT imager (γ-CUBE)
3) a high-throughput CT scanner (X-CUBE)
SERVICES OFFERED BY THE ASSET
Development of healing devices in animal model
Carrying out animal experimentation projects in accordance with the AALAC animal welfare protection regulations We offer the licensing management services in animal experimentation and procedures to perform in vivo experimental proposals.
Evaluation of the effect of compounds in longitudinal animla model
We offer the possibility to perform long term animal studies to evaluate the effect of compounds during the development of certain diseases.
Preclinical MRI Imaging in rodents
Assessment of MRI studies in rodents with an MRI 11.7 Tesla magnet, operating at a proton resonance frequency of 500MHz (actively shielded ultra refrigerated superconducting).
Preclinical PET SPECT Imaging in rodents
Assessment of in vivo and ex vivo nuclear imaging studies of in-house produced radiolabelled compound or suspension. We offer a state-of-the-art imaging resources in Positron Emission Tomography (PET), Single Photon Emission Computerized Tomography (SPECT) and X ray Computerized Tomography (CT).
Synthesis and labelling of radiotracer for pharmacokinetics/dynamic studies.
The facility allows the synthesis of a wide range of PET and SPECT radiotracers, as well as the design of new labelled structures to undertake pharmacokinetic and pharmacodynamic studies. Offer the analyse of radiolabelled metabolites in blood, tissue samples, cell culture, biomolecules, suspension or devices.
ENTITY MANAGING THE ASSET
Contact person:
Angel Martínez
external.services@cicbiomagune.es